Publications by authors named "Josep Piulats"

Claim this Profile
I
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients.
Takami Sato, Marcus O Butler, Sophie Piperno-Neumann, Jessica C Hassel, Paul Nathan, Josep M Piulats

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: "Tebentafusp Versus Nivolumab Plus Ipilimumab for Metastatic Uveal Melanoma: An E‑Value Sensitivity Analysis Assessing Effect of Unmeasured Confounders on Observational Associations".
Claire Watkins, Luis Del Carpio, Josep M Piulats

Clin Drug Investig· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abemaciclib plus abiraterone in patients with metastatic castration-resistant prostate cancer (CYCLONE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Matthew Smith, Josep Piulats, Tilman Todenhöfer, Jae-Lyun Lee, José Arranz Arija

Lancet Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular determinants of survival in metastatic uveal melanoma: The impact of SF3B1 mutations.
Luis P Del Carpio, Mar Varela, Mikel Portu, Sergi Villatoro, Elvira Purqueras, Josep M Piulats

Eur J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D.
Evan Y Yu, Cristiano Ferrario, Mark D Linch, Michael Stoeckle, Brigitte Laguerre, Josep M Piulats

Eur Urol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tebentafusp, a T cell engager, promotes macrophage reprogramming and in combination with IL-2 overcomes macrophage immunosuppression in cancer.
Esra Güç, Agatha Treveil, Emma Leach, Anna Broomfield, Antonio Camera, Josep M Piulats

Nat Commun· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical protocol phase II study of tumor infiltrating lymphocytes in advanced tumors with alterations in the SWI/SNF complex: the TILTS study.
Juan Martin-Liberal, Elena Garralda, Jesús García-Donas, Juan José Soto-Castillo, Alberto Mussetti, Josep Maria Piulats

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial.
Alonso Garcia-Ruiz, Carlos Macarro, Francesca Zacchi, Rafael Morales-Barrera, Francesco Grussu, Josep M Piulats

Eur Urol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing ctDNA: An Updated Review of a Promising Clinical Tool for the Management of Uveal Melanoma.
Mar Varela, Sergi Villatoro, Daniel Lorenzo, Josep Maria Piulats, Josep Maria Caminal

Cancers (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial.
Michael J Morris, Daniel Castellano, Ken Herrmann, Johann S de Bono, Neal D Shore, Josep M Piulats

Lancet· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate-Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 Study.
Evan Y Yu, William R Berry, Howard Gurney, Margitta Retz, Henry J Conter, Josep M Piulats

Eur Urol Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma.
Joseph J Sacco, Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Josep M Piulats

J Immunother Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma.
Laura Lorenzo-Sanz, Marta Lopez-Cerda, Victoria da Silva-Diz, Marta H Artés, Sandra Llop, Josep M Piulats

Nat Commun· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1,4-dihydroxy quininib activates ferroptosis pathways in metastatic uveal melanoma and reveals a novel prognostic biomarker signature.
Valentina Tonelotto, Marcel Costa-Garcia, Eve O'Reilly, Kaelin Francis Smith, Kayleigh Slater, Josep M Piulats

Cell Death Discov· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma.
Jessica C Hassel, Sophie Piperno-Neumann, Piotr Rutkowski, Jean-Francois Baurain, Max Schlaak, Josep M Piulats

N Engl J Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Driver mutations in and genes as potential targets for precision immunotherapy in uveal melanoma patients.
Sandra García-Mulero, Roberto Fornelino, Marco Punta, Stefano Lise, Mar Varela, Josep María Piulats

Oncoimmunology· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of the Uveal Melanoma-Associated Mutation Q209P from Liquid Biopsy Using CRISPR/Cas12a Technology.
Carmen Escalona-Noguero, Hernán Alarcón-Iniesta, María López-Valls, Luis Paul Del Carpio, Josep M Piulats

Anal Chem· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MBD4-associated neoplasia syndrome: screening of cases with suggestive phenotypes.
Mariona Terradas, Noemi Gonzalez-Abuin, Sandra García-Mulero, Julen Viana-Errasti, Gemma Aiza, Josep M Piulats

Eur J Hum Genet· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study.
Wassim Abida, David Campbell, Akash Patnaik, Alan H Bryce, Jeremy Shapiro, Josep M Piulats

Eur Urol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in glucose metabolic activity in liver metastasis separates two groups of metastatic uveal melanoma patients with different prognosis.
Luis P Del Carpio, María Asunción Algarra, Aida Sabaté-Llobera, Alejo Rodriguez-Vida, Susana Rossi-Seoane, Josep M Piulats

Cancer Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy.
Juan José Soto-Castillo, Lucía Llavata-Marti, Roser Fort-Culillas, Pablo Andreu-Cobo, Rafael Moreno, Josep M Piulats

Int J Mol Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery.
Andrea Plaja, Iris Teruel, Maria Ochoa-de-Olza, Marc Cucurull, Álvaro Javier Arroyo, Josep María Piulats

Int J Mol Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics.
Maria Lozano-Rabella, Andrea Garcia-Garijo, Jara Palomero, Anna Yuste-Estevanez, Florian Erhard, Josep Maria Piulats

Clin Cancer Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and anti-androgen resistance.
Andrea Alegre-Martí, Alba Jiménez-Panizo, Adrián Martínez-Tébar, Coralie Poulard, M Núria Peralta-Moreno, Josep M Piulats

Sci Adv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rucaparib or Physician's Choice in Metastatic Prostate Cancer.
Karim Fizazi, Josep M Piulats, M Neil Reaume, Peter Ostler, Ray McDermott

N Engl J Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis